No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Biomarkers / blood
-
Child
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Humans
-
Induction Chemotherapy / adverse effects*
-
Male
-
Non-alcoholic Fatty Liver Disease / chemically induced*
-
Non-alcoholic Fatty Liver Disease / diagnosis
-
Non-alcoholic Fatty Liver Disease / pathology
-
Obesity / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Tomography, X-Ray Computed
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
gamma-Glutamyltransferase / blood
Substances
-
Biomarkers
-
Vincristine
-
gamma-Glutamyltransferase
-
Asparaginase
-
Prednisone
-
Daunorubicin